alere inc (ALR:New York)
John A. Quelch C.B.E., Ph.D., DBA, MBA, MS
Director and Chairman of Nominating & Corporate Governance Committee, Alere Inc.
|Age||Total Calculated Compensation||This person is connected to 137 board members in 9 different organizations across 11 different industries.|
See Board Relationships
Prof. John A. Quelch, CBE, Ph.D, DBA, MBA, MS is the Charles Edward Wilson Professor of Business Administration at Harvard Business School. Prof. Quelch has been Professor in Health Policy and Management at Harvard School of Public Health since January 2013. Prof. Quelch is a Consultant to over fifty leading firms including American Airlines, Apple Computer, AT&T, Coca-Cola, Colgate-Palmolive, Fidelity Investments, General Electric, Gillette, Hoffman LaRoche, Honeywell, ...
51 Sawyer RoadPhone: 781-647-3900
Waltham, Massachusetts 02453
Board Members Memberships*
Former Independent Non Executive Director
Non Executive Director
Member of the Advisory Board
Former Non-Executive Director
Director and Chairman of Nominating & Corporate Governance Committee
Independent Director, Member of Compensation & Management Development Committee and Member of Audit & Affiliated Transactions Committee
Former Director and Member of Clinical Quality Committee
Harvard Business School
University of Pennsylvania - The Wharton School
University of Oxford
University of Oxford
Harvard School of Public Health
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Walter M. Rosebrough Jr.||Chief Executive Officer, President, Director and Member of Compliance Committee|
|Roger J. Medel M.D.||Co-Founder, Chief Executive Officer, Director and Chairman of Executive Committee|
|Norman D. Schwartz||Chairman, Chief Executive Officer and President|
Bio-Rad Laboratories, Inc.
|Robert F. Friel||Chairman, Chief Executive Officer, President and Member of Finance Committee|
|Alexandre Merieux||Chief Executive Officer, Director and Member of Strategy Committee|
|€669.5K||Compensation as of Fiscal Year 2014.|